These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 13906375)
1. Parstelin in anxiety states and depression. HEMPHILL RE; FOSTER AR J Coll Gen Pract; 1962 May; 5(2):238-45. PubMed ID: 13906375 [No Abstract] [Full Text] [Related]
2. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety. GODDARD ES Can Psychiatr Assoc J; 1962; 7(Suppl)():87-90. PubMed ID: 13899397 [No Abstract] [Full Text] [Related]
3. Treatment of anxiety states by antidepressant drugs. SARGANT W; DALLY P Br Med J; 1962 Jan; 1(5270):6-9. PubMed ID: 14497198 [No Abstract] [Full Text] [Related]
4. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions. LESSE S Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348 [No Abstract] [Full Text] [Related]
5. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states. BRAM G Can Psychiatr Assoc J; 1962; 7(Suppl)():84-6. PubMed ID: 13872435 [No Abstract] [Full Text] [Related]
6. Combined tranlcypromine and trifluoperazine therapy in general medicine. LEWIS RA Can Psychiatr Assoc J; 1962; 7(Suppl)():74-6. PubMed ID: 14464901 [No Abstract] [Full Text] [Related]
7. The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin). SCHIELE BC Am J Psychiatry; 1960 Sep; 117():245-6. PubMed ID: 13747600 [No Abstract] [Full Text] [Related]
8. Combined tranylcypromine-trifluoperazine therapy in obstetrics and gynaecology. PRUETER GW Can Psychiatr Assoc J; 1962; 7(Suppl)():77-83. PubMed ID: 14489022 [No Abstract] [Full Text] [Related]
9. A clinical trial of an antidepressant, tranylcy-promine ("Parnate"). KINGSTON WR Med J Aust; 1962 Jun; 49(1)():1011-2. PubMed ID: 14456153 [No Abstract] [Full Text] [Related]
10. Experiences with N, N-dimethyl-2-phenylcyclo-propylamine in chronic anergic schizophrenic patients. KURLAND AA; McCUSKER K J Neuropsychiatr; 1962; 3():190-4. PubMed ID: 14460738 [No Abstract] [Full Text] [Related]
11. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation. LESSE S N Y State J Med; 1961 Jun; 61():1898-903. PubMed ID: 13761180 [No Abstract] [Full Text] [Related]
12. Tranylcypromine-trifluoperazine in the management of emotional distress. BAUM ES Int Rec Med; 1961 May; 174():303-6. PubMed ID: 13687959 [No Abstract] [Full Text] [Related]
13. Tranylcypromine and trifluoperazine in the management of the menopausal syndrome. MAZZA PA Dis Nerv Syst; 1962 Apr; 23():224-5. PubMed ID: 14471846 [No Abstract] [Full Text] [Related]
14. Tranylcypromine (parnate) a new monoamine oxidase inhibitor. LEMERE F Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582 [No Abstract] [Full Text] [Related]
15. Neuropharmacology of tranylcypromine and trifluoperazine. TEDESCHI RE; TEDESCHI DH; FELLOWS EJ Can Psychiatr Assoc J; 1962; 7(Suppl)():55-9. PubMed ID: 13920073 [No Abstract] [Full Text] [Related]
16. Accidental overdose of "Parstelin". MIDWINTER RE Br Med J; 1962 Dec; 2(5321):1755-6. PubMed ID: 13935621 [No Abstract] [Full Text] [Related]